✦ LIBER ✦

Effects of downstream processing on structural integrity and immunogenicity in the manufacture of papillomavirus type 16 L1 virus-like particles

✍ Scribed by Don Yong Chang, Hyoung Jin Kim, Hong-Jin Kim

Book ID: 118824765
Publisher: The Korean Society for Biotechnology and Bioengineering
Year: 2012
Tongue: English
Weight: 859 KB
Volume: 17
Category: Article
ISSN: 1226-8372
DOI: 10.1007/s12257-012-0067-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, immunogenicity, and efficacy of

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women

✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naï

Immunogenicity of a Prophylactic Quadriv

Immunogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescent Transplant Recipients

✍ Gomez-Lobo, V.; Moudgil, A.; Whyte, T.; Kaufman, S.; Torres, C.; Mete, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Dose-ranging studies of the safety and i

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women

✍ Kenneth H Fife; Cosette M Wheeler; Laura A Koutsky; Eliav Barr; Darron R Brown; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Expression of codon optimized major caps

Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles

✍ N. Hanumantha Rao; P. Baji Babu; L. Rajendra; R. Sriraman; Yuk-Ying S. Pang; Joh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 719 KB

Comparison of the Immunogenicity and Rea

Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

✍ Block, S. L.; Nolan, T.; Sattler, C.; Barr, E.; Giacoletti, K. E.D.; Marchant, C 📂 Article 📅 2006 🏛 American Academy of Pediatrics 🌐 English ⚖ 409 KB

Efficacy of a bivalent L1 virus-like par

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

✍ Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 185 KB